A
15.68
0.06 (0.38%)
| Penutupan Terdahulu | 15.62 |
| Buka | 15.58 |
| Jumlah Dagangan | 2,319,104 |
| Purata Dagangan (3B) | 2,929,126 |
| Modal Pasaran | 2,329,266,944 |
| Harga / Pendapatan (P/E Ke hadapan) | 129.87 |
| Harga / Jualan (P/S) | 3.19 |
| Harga / Buku (P/B) | 202.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 24 Feb 2026 |
| Margin Keuntungan | -25.77% |
| Margin Operasi (TTM) | -18.74% |
| EPS Cair (TTM) | -1.14 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 22.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6,465.30% |
| Nisbah Semasa (MRQ) | 2.76 |
| Aliran Tunai Operasi (OCF TTM) | -11.25 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -24.32 M |
| Pulangan Atas Aset (ROA TTM) | -9.33% |
| Pulangan Atas Ekuiti (ROE TTM) | -291.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Alphatec Holdings, Inc. | Menaik | Menaik |
AISkor Stockmoo
1.5
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.50 |
|
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 21.42% |
| % Dimiliki oleh Institusi | 63.24% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bnp Paribas Asset Management Holding S.A. | 30 Sep 2025 | 3,256,357 |
| Next Century Growth Investors Llc | 30 Sep 2025 | 2,279,383 |
| Cerity Partners Llc | 30 Sep 2025 | 1,854,156 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 27.00 (Barclays, 72.19%) | Beli |
| Median | 24.50 (56.25%) | |
| Rendah | 21.00 (Morgan Stanley, 33.93%) | Pegang |
| Purata | 24.13 (53.89%) | |
| Jumlah | 7 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 19.28 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 12 Jan 2026 | 24.00 (53.06%) | Beli | 17.59 |
| 31 Oct 2025 | 24.00 (53.06%) | Beli | 18.99 | |
| Needham | 12 Jan 2026 | 22.00 (40.31%) | Beli | 17.59 |
| 31 Oct 2025 | 22.00 (40.31%) | Beli | 18.99 | |
| Barclays | 07 Jan 2026 | 27.00 (72.19%) | Beli | 21.97 |
| 03 Nov 2025 | 23.00 (46.68%) | Beli | 19.29 | |
| Freedom Capital Markets | 11 Dec 2025 | 25.00 (59.44%) | Beli | 19.91 |
| Morgan Stanley | 10 Nov 2025 | 21.00 (33.93%) | Pegang | 20.24 |
| Canaccord Genuity | 31 Oct 2025 | 25.00 (59.44%) | Beli | 18.99 |
| Piper Sandler | 31 Oct 2025 | 25.00 (59.44%) | Beli | 18.99 |
| Stifel | 31 Oct 2025 | 24.00 (53.06%) | Beli | 18.99 |
| 28 Oct 2025 | 20.00 (27.55%) | Beli | 16.65 | |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion |
| 12 Jan 2026 | Pengumuman | ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook |
| 07 Nov 2025 | Pengumuman | ATEC Mourns Passing of Board Member Jeffrey P. Rydin |
| 30 Oct 2025 | Pengumuman | ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |